Accessibility Menu

Novo Nordisk A/s

(FRA) NOVC

Current PriceN/A
Market CapN/A
Since IPO (2001)+3,248%
5 Year+13%
1 Year-42%
1 Month+3%

Novo Nordisk A/s Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$43.90K

Net Income (TTM)

$16.33K

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

NOVC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novo Nordisk A/s

Industry

Pharmaceuticals

Employees

68,794

CEO

Maziar Mike Doustdar

NOVC Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Novo Nordisk A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$12.96K

+1.2%

Gross Profit

$11.14K

+1.3%

Gross Margin

85.96%

+1.0%

Market Cap

N/A

N/A

Market Cap/Employee

$2.04

+0.5%

Employees

68,794

+0.9%

Net Income

$6.50K

+1.7%

EBITDA

$8.47K

+1.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$2.83K

+0.5%

Accounts Receivable

$11.05K

+1.2%

Inventory

$6.87K

+1.2%

Long Term Debt

$15.95K

+1.2%

Short Term Debt

$3.64K

+1.2%

Return on Assets

23.27%

+0.9%

Return on Invested Capital

50.10%

+0.9%

Free Cash Flow

$1.62K

+0.4%

Operating Cash Flow

$3.13K

+0.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,606.84+0.00%
^DJIDJI
$51,304.31+0.00%
^IXICNASDAQ
$27,069.44-0.00%
BTCBitcoin
$67,519.00-0.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
HPEHewlett Packard Enterprise
$56.15+0.19%
ONDSOndas
$13.58+0.01%
IBITiShares Bitcoin Trust
$38.05-0.06%
FFord Motor Company
$16.15-0.03%

Questions About NOVC

What is the current price of Novo Nordisk A/s?

Novo Nordisk A/s is trading at N/A per share.

What is the 52-week range for Novo Nordisk A/s?

Over the past 52 weeks, Novo Nordisk A/s has traded between N/A and N/A.

How much debt does Novo Nordisk A/s have?

As of the most recent reporting period, Novo Nordisk A/s reported total debt of $19.59B.

How much cash does Novo Nordisk A/s have on hand?

Novo Nordisk A/s reported $2.83B in cash and cash equivalents in its most recent financial results.

What is Novo Nordisk A/s’s dividend yield?

Novo Nordisk A/s does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.